- Filed
- Mar 20, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2019 · Mar 20, 2020 | 14.86M sh |
| Shares Diluted | FY 2019 · Dec 31, 2019 | 14.53M sh |
| Shares Diluted | FY 2019 · Dec 31, 2018 | 4.74M sh |
| Capex | FY 2019 · Dec 31, 2019 | −$976.82K |
| Capex restated | FY 2019 · Dec 31, 2018 | −$42.41K |
| Cost Of Revenue | FY 2019 · Dec 31, 2019 | −$871.43K |
| Cost Of Revenue | FY 2019 · Dec 31, 2018 | −$516.96K |
| Operating Cash Flow | FY 2019 · Dec 31, 2018 | −$888.08K |
| Current Liabilities | FY 2019 · Dec 31, 2018 | $1.38M |
| Total Liabilities | FY 2019 · Dec 31, 2018 | $1.91M |
| Current Assets | FY 2019 · Dec 31, 2018 | $308.61K |
| Total Assets | FY 2019 · Dec 31, 2018 | $2.96M |
| Net Income | FY 2019 · Dec 31, 2018 | −$1.24M |
| Operating Income | FY 2019 · Dec 31, 2018 | −$1.19M |
| Revenue restated | FY 2019 · Dec 31, 2018 | $274.24K |
| Cash And Equivalents | FY 2019 · Dec 31, 2017 | $38.94K |
| Stockholders Equity | FY 2019 · Dec 31, 2017 | −$6.6M |